UGT8-IN-1
UGT8-IN-1 is an orally active, blood-brain barrier-penetrating small-molecule inhibitor that targets UGT8 (ceramide galactosyltransferase) . By inhibiting pathways involved in sphingolipid synthesis, it is used in research into the mechanisms of neurological disorders such as lysosomal storage diseases.
Product Specifications
CAS Number
2414349-93-0
Field of Research
Metabolism Research
Purity
99.60% (May vary between batches)
Smiles
C (NC) (=O) C=1C=2C (=C (C (F) (F) F) C=C (N2) N3CCC (OC (N[C@H] (COC (F) (F) F) C) =O) CC3) SC1
Molecular Formula
C20H22F6N4O4S
Molecular Weight
528.47
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6283272-01 0.2 mL
CD45, CT (PTPRC, CD45, Receptor-type tyrosine-protein phosphatase C, Leukocyte common antigen, T200, CD45) (FITC)
Sign In for Pricing
View Details MBS6283272-02 5x 0.2 mL
CD45, CT (PTPRC, CD45, Receptor-type tyrosine-protein phosphatase C, Leukocyte common antigen, T200, CD45) (FITC)
Sign In for Pricing
View Details 
251730 50 µL
SLC27A5 (Solute Carrier Family 27 (Fatty Acid Transporter), Member 5, ACSB, ACSVL6, FACVL3, FATP5, FLJ22987, VLACSR, VLCS-H2, VLCSH2)
Sign In for Pricing
View Details